John C Bischof Selected Research

John C Bischof Research Topics

Disease

34	Neoplasms (Cancer) 01/2021 - 07/2002
8	Hyperthermia 01/2018 - 03/2003
7	Dehydration (Water Stress) 12/2011 - 03/2003
5	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 08/2004
5	Inflammation (Inflammations) 08/2008 - 05/2003
4	Carcinoma (Carcinomatosis) 01/2016 - 08/2002
3	Necrosis 01/2012 - 08/2004
3	Vascular System Injuries 09/2007 - 10/2002
2	Wounds and Injuries (Trauma) 04/2016 - 01/2003
2	Hypoxia (Hypoxemia) 06/2005 - 04/2005
2	Sickle Cell Anemia (Hemoglobin S Disease) 04/2005 - 05/2003
1	Infections 01/2021
1	Experimental Melanoma 01/2019
1	Breast Neoplasms (Breast Cancer) 01/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2017
1	Reperfusion Injury 04/2016
1	Meningitis 01/2014
1	Hepatocellular Carcinoma (Hepatoma) 10/2012
1	Neoplasm Metastasis (Metastasis) 04/2011
1	Fibrosarcoma 09/2007
1	Burns 12/2005
1	Renal Cell Carcinoma (Grawitz Tumor) 04/2005
1	Acute-Phase Reaction 05/2003
1	Leiomyoma (Uterine Fibroids) 02/2003

Drug/Important Bio-Agent (IBA)

10	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2013 - 04/2004
7	IceIBA 04/2016 - 03/2003
5	GoldIBA 05/2013 - 04/2006
5	CytokinesIBA 08/2008 - 04/2004
4	Proteins (Proteins, Gene)FDA Link 01/2019 - 05/2003
3	Biocompatible Materials (Biomaterials)IBA 04/2020 - 12/2005
3	CYT-6091IBA 06/2009 - 07/2007
3	Gold Colloid (Colloidal Gold)IBA 06/2009 - 04/2006
2	AntigensIBA 01/2019 - 01/2014
2	Pharmaceutical PreparationsIBA 01/2017 - 04/2016
2	Biological ProductsIBA 01/2016 - 02/2011
2	SuspensionsIBA 12/2011 - 02/2004
2	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 07/2007 - 04/2006
2	NF-kappa B (NF-kB)IBA 06/2005 - 04/2005
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	polycaprolactoneIBA 04/2020
1	caprolactoneIBA 01/2018
1	IronIBA 01/2017
1	Silicon Dioxide (Silica)FDA LinkGeneric 01/2016
1	Phosphates (Orthophosphate)IBA 01/2016
1	chinese inkIBA 01/2014
1	LatexIBA 01/2014
1	Blood Proteins (Serum Proteins)IBA 08/2012
1	LigandsIBA 08/2012
1	Small Interfering RNA (siRNA)IBA 02/2012
1	Arsenic Trioxide (Trisenox)FDA Link 01/2012
1	Cisplatin (Platino)FDA LinkGeneric 01/2012
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 10/2010
1	CollagenIBA 03/2010
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 03/2010
1	Acetylcholine (Acetylcholine Chloride)FDA Link 03/2010
1	Mannitol (Osmitrol)FDA LinkGeneric 03/2010
1	SolutionsIBA 05/2009
1	LipidsIBA 05/2009
1	Dextrans (Dextran)FDA Link 11/2007
1	ferric oxide (iron oxide)IBA 11/2007
1	Surface-Active Agents (Surfactants)IBA 11/2007
1	Sulfhydryl Compounds (Thiols)IBA 07/2007
1	TESIBA 02/2006
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 06/2005
1	Monoclonal AntibodiesIBA 06/2005
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 06/2005
1	Blocking AntibodiesIBA 06/2005
1	Dexamethasone (Maxidex)FDA LinkGeneric 06/2005
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 06/2005
1	polynitroxyl-albuminIBA 04/2005
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2005
1	GlobinsIBA 04/2005
1	Oxygen (Dioxygen)IBA 06/2004
1	Serum Amyloid P-ComponentIBA 05/2003

Therapy/Procedure

22	Therapeutics 01/2021 - 07/2002
9	Cryosurgery 01/2019 - 10/2002
3	Immunotherapy 01/2021 - 01/2019
3	Drug Therapy (Chemotherapy) 05/2013 - 06/2004
2	Electrodes (Electrode) 04/2020 - 01/2015
2	Transplantation 11/2017 - 04/2016
2	Radiotherapy 10/2012 - 01/2012
2	Aftercare (After-Treatment) 10/2012 - 04/2006
2	Intravenous Injections 06/2009 - 09/2007
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2017
1	Rewarming 04/2016
1	Combined Modality Therapy 05/2013
1	Induced Hyperthermia (Thermotherapy) 01/2012
1	Radiofrequency Ablation 01/2009
1	Lasers (Laser) 11/2007
1	Salpingo-oophorectomy 02/2003
1	Hysterectomy 02/2003